Aspen Pharmacare Holdings Ltd (JSE:APN)
R 244.27 -2.73 (-1.11%) Market Cap: 108.51 Bil Enterprise Value: 133.03 Bil PE Ratio: 22.29 PB Ratio: 1.27 GF Score: 85/100

Aspen Pharmacare Holdings Ltd Virtual Investor Day Transcript

Dec 11, 2020 / 12:00PM GMT
Release Date Price: R127.44 (-2.53%)
Stephen Bradley Saad
Aspen Pharmacare Holdings Limited - Group CEO & Executive Director

Good afternoon, everybody, and welcome to the Aspen Investor Day. It's our presentation here. We hope to take you through some of our objectives going forward.

But if I would like to start, it's maybe just cover a little bit of this year because it's been a very interesting year for us, I'd say probably best characterized by saying it's been both a rewarding and an incredibly stressful year, rewarding not only on the financial front in that we've got a reshaped base and a very clear strategy that we will articulate with you -- to you over the next hour or so. We've also had growth, as you know, of 9% in our financial year 2020 in spite of COVID. And we've had a -- we've managed to strengthen our balance sheet significantly.

It's -- we've not only, in this period, in terms of rewards, received dividends. And those dividends are really in the form of our -- that our new strategic direction has delivered for us. We have made, although a small company in global pharma terms, a very large

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot